Safety and Immunogenicity of Fluzone® Quadrivalent, Flublok® Quadrivalent, and Fluzone® High-Dose, Influenza Vaccines, 2018-2019 Formulations
Clinical trial NCT03617523 · COMPLETED
Trial details
- NCT number
- NCT03617523
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-09-10
- Primary completion
- 2018-11-12
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.